Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of BBIBP bOPV in Healthy Kenyan Infants
NCT02434770Phase 3Completed
- Sponsor
- PATH
- Start
- Aug 2015
- Primary completion
- Jun 2016
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of bivalent oral poliovirus vaccine in poliomyelitis, sponsored by PATH. Started Aug 2015; status: completed.
02
Drugs
bivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT02434770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434770.